Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Alterations in serum lipids and apolipoproteins in male Type 1 (insulin-dependent) diabetic patients with microalbuminuria

  • 75 Accesses

  • 18 Citations

Summary

The relationships between serum lipid, apolipoprotein levels and urinary albumin excretion were investigated in 20 male Type 1 (insulin-dependent) diabetic patients with microalbuminuria (overnight urinary albumin excretion between 10 and 200 μg/min), in 18 male Type 1 diabetic patients without microalbuminuria and in 18 male control subjects. In the microalbuminuric patients low density lipoprotein cholesterol was higher than in the control subjects (p<0.05); the high density lipoprotein/low density lipoprotein cholesterol ratio was lower than in the normoalbuminuric diabetic patients (p<0.05), and in the control subjects (p<0.01); apolipoprotein B was higher than in the normoalbuminuric patients (p<0.05); the apolipoprotein A1/B ratio was lower than in the normoalbuminuric diabetic patients (p<0.05). Serum triglyceride was higher in the microalbuminuric diabetic patients and in the control subjects than in the normoalbuminuric diabetic patients (p<0.05, for both), but was not different between the microalbuminuric diabetic patients and the control subjects. No significant differences between the 3 groups were present with respect to serum cholesterol, high density lipoprotein cholesterol and apolipoprotein A1. In the 2 combined Type 1 diabetic groups there were significant correlations between urinary albumin excretion and the high density lipoprotein/low density lipoprotein cholesterol ratio (R -0.40, p<0.02), apolipoprotein B (R0.35, p<0.05) and the apolipoprotein A1/B ratio (R -0.44, p<0.01). These results indicate microalbuminuria related differences in lipid and apolipoprotein levels in male Type 1 diabetic patients, which may contribute to an increased risk of cardiovascular disease.

References

  1. 1.

    Kessler II (1971) Mortality experience of diabetic patients. A twenty-six year follow-up study. Am J Med 51: 715–724

  2. 2.

    Kannel WB, McGee DL (1979) Diabetes and cardiovascualr disease. The Framingham study. JAMA 241: 2035–2038

  3. 3.

    Green A, Hougaard P (1984) Epidemiological studies of diabetes mellitus in Denmark: 5. Mortality and causes of death among insulin treated-diabetic patients. Diabetologia 26: 190–194

  4. 4.

    Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596

  5. 5.

    Borch-Johnsen K, Kreiner S (1987) Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294: 1651–1654

  6. 6.

    Christiansen JS (1978) Cigarette smoking and prevalence of microangiopathy in juvenile onset insulin-dependent diabetes mellitus. Diabetes Care 1: 146–149

  7. 7.

    Telmer S, Christiansen JS, Andersen AR, Nerup J, Deckert T (1984) Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 215: 63–68

  8. 8.

    Parving HH, Andersen AR, Smidt UM, Oxenbøll B, Edsberg B, Christiansen JS (1983) Diabetic nephropathy and arterial hypertension. Diabetologia 24: 10–12

  9. 9.

    Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30: 144–148

  10. 10.

    Winocour PH, Durrington PN, Ishola M, Anderson DC, Cohen H (1987) Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J 294: 1648–1651

  11. 11.

    Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH (1980) Hyperglycemia and plasma lipid levels. A prospective study of young insulin-dependent diabetic patients. N Eng J Med 302: 650–654

  12. 12.

    Durrington PN (1980) Serum high density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration. Clin Chim Acta 104: 11–23

  13. 13.

    Eckel RH, Albers JJ, Cheung MC, Wahl PW, Lindgren FT, Bierman EL (1981) High density lipoprotein composition in insulin dependent diabetes mellitus. Diabetes 30: 132–138

  14. 14.

    Lopes-Virella MF, Wohltmann HJ, Loadholt CB, Buse MG (1981) Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: Relationship with control. Diabetologia 21: 216–223

  15. 15.

    Laakso M, Voutilainen E, Sarlund H, Aro A, Pyörälä K, Penttila I (1985) Inverse relationship of serum HDL and HDL2 cholesterol to c-peptide level in middle-aged insulin-treated diabetics. Metabolism 34: 715–720

  16. 16.

    Winocour PH, Durrington DN, Ishola M, Anderson DC (1986) Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet I: 1176–1178

  17. 17.

    Weisweiler P, Schwandt P (1987) Type 1 (insulin-dependent) versus Type 2 (non-insulin dependent) diabetes mellitus: characterization of serum lipoprotein alterations. Eur J Clin Invest 17: 87–91

  18. 18.

    Laakso M, Sarlund H, Ehnholm C, Voutilainen E, Aro A, Pyörälä K (1987) Relationship between postheparin plasma Upases and high-density lipoprotein cholesterol in different types of diabetes. Diabetologia 30: 703–706

  19. 19.

    Eckel RH, McLean E, Albers JJ, Cheung MC, Bierman EL (1981) Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care 4: 447–453

  20. 20.

    Dornan TL, Carter RD, Bron AJ, Turner RC, Mann JI (1982) Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy. Diabetologia 22: 167–170

  21. 21.

    Vannini P, Ciavarella A, Flammini M, Bargossi AM, Forlani G, Borgnino LC, Orsoni G (1984) Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care 7: 151–154

  22. 22.

    Jensen T, Stender S, Deckert T (1988) Abnormalities in plasma concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31: 142–145

  23. 23.

    Viberti GC, Jarret RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet I: 1430–1432

  24. 24.

    Mogensen CE, Christensen CK, Vittinghus E (1983) The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes 32 [Suppl 2]: 64–78

  25. 25.

    Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89–93

  26. 26.

    Mogensen CE (1971) Urinary albumin excretion in early and long-term juvenile diabetes. Scand J Clin Lab Invest 28: 183–193

  27. 27.

    Donker AJM, van der Hem GK, Sluiter WJ, Beekhuis H (1977) A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20: 97–103

  28. 28.

    Jones DY, Judd JT, Taylor PR, Campbell WS, Nair PP (1988) Menstrual cycle effect on plasma lipids. Metabolism 37: 1–2

  29. 29.

    Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determinations in high density lipoproteins separated by three different methods. Clin Chem 23: 882–884

  30. 30.

    Lie RF, Schmitz JM, Pierre KJ, Gochman N (1976) Cholesterol oxidase based determination by continuous flow analysis of total and free cholesterol in serum. Clin Chem 22: 1627–1630

  31. 31.

    Bucolo G, David H (1973) Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 19: 475–482

  32. 32.

    Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499–502

  33. 33.

    Flückiger R, Winterthalter KH (1976) In vitro synthesis of hemoglobin Alc. FEBS Letters 71: 356–360

  34. 34.

    Diem K (1980) Wissenschaftliche Tabellen Geigy 8th edition. Ciba Geigy, Basel, Switzerland

  35. 35.

    Duncan DB (1955) Multiple range and multiple F-tests. Biometrics 11: 1–42

  36. 36.

    Avogaro P, Cazzolato G, Bittolo Bon G, Quinci GB (1979) Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet I: 901–903

  37. 37.

    Ball M, Mann JI (1986) Apoproteins: predictors for coronary heart disease? Br Med J 293: 769–770

  38. 38.

    Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 298: 784–788

  39. 39.

    Watts GF, Naumova R, Slavin BM, Morris RW, Houlston R, Kubal C, Shaw KM (1989) Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria. Diabetic Med 6: 25–30

  40. 40.

    Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC (1989) Plasma lipid and coagulation factor concentrations in insulin-dependent diabetics with microalbuminuria. Br Med J 298: 487–490

  41. 41.

    Marsh JB, Drabkin DK (1960) Experimental reconstruction of metabolic patterns of lipid nephrosis: Key role of hepatic protein synthesis in hyperlipidemia. Metabolism 9: 946–955

  42. 42.

    Gitlin D, Cornwall DG, Nakasoto D, Oncley JL, Hughes WL Jr, Janeway CA (1958) Studies on the metabolism of plasma proteins in the nephrotic syndrome II. The lipoproteins. J Clin Invest 37: 172–184

  43. 43.

    de Mendoza SG, Kashyap ML, Chen CY, Lutmer RF (1976) High density lipoproteinuria in nephrotic syndrome. Metabolism 26: 1143–1149

  44. 44.

    Kashyap ML, Ooi BS, Hynd BA (1979) Sequestration and excretion of high density lipoproteins by the kidney in human nephrotic syndrome. Artery 6: 108–121

  45. 45.

    Tikkanen MJ, Viikari J, Åkerblom HK, Pesonen E (1988) Apolipoprotein B polymorphism and altered apolipoprotein B and low density lipoprotein cholesterol concentration in Finnish children. Br Med J 296: 169–170

  46. 46.

    Eto M, Watanake K, Iwashima Y, Morikawa A, Oshima E, Sekiguchi M, Ishii K (1986) Apolipoprotein E polymorphism and hyperlipidemia in Type II diabetics. Diabetes 35: 1374–1382

  47. 47.

    Austin MA, Krauss RM (1986) Genetic control of low density lipoprotein subclasses. Lancet II: 592–595

  48. 48.

    Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial Results. JAMA 251: 351–374

  49. 49.

    Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Eng J Med 318: 1315–1321

  50. 50.

    Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella MF (1987) Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low density lipoproteins. Diabetologia 30: 916–923

  51. 51.

    Feldt-Rasmussen B (1986) Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29: 282–286

  52. 52.

    Ross R (1986) The pathogenesis of atherosclerosis: an update. N Eng J Med 314: 488–500

  53. 53.

    Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet II: 1309–1311

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dullaart, R.P.F., Dikkeschei, L.D. & Doorenbos, H. Alterations in serum lipids and apolipoproteins in male Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 32, 685–689 (1989). https://doi.org/10.1007/BF00274257

Download citation

Key words

  • Lipoproteins
  • apolipoproteins
  • microalbuminuria
  • incipient nephropathy
  • Type 1 (insulin-dependent) diabetes mellitus